ADMA News and Press, ADMA Biologics Inc From 11/16/23

RAMSEY, N.J. and BOCA RATON, Fla. and LAUREL, Md., Nov. 16, 2023 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-...

2023-11-09 16:25:06 ET Adma Biologics (NASDAQ: ADMA) stock experienced a nice pop in Thursday's trading session, after the company unveiled its latest set of quarterly earnings after market hours the previous day. Happy investors were trading the shares up by almost 5% late in the s...

2023-11-09 15:23:33 ET Summary Today, we revisit ADMA Biologics, Inc., after this small cap biopharma just delivered better than expected Q3 results after the bell on Wednesday. The company is executing strongly, just became free cash flow positive for the first time, and boosted ...

2023-11-08 19:11:09 ET ADMA Biologics, Inc. (ADMA) Q3 2023 Earnings Conference Call November 8, 2023, 4:30 pm ET Company Participants Skyler Bloom - Head, Business Development & Corporate Strategy Adam Grossman – President & CEO Brian Lenz - EVP, C...

2023-11-08 16:11:07 ET More on ADMA Biologics ADMA Biologics: From Plasma To Profits With A Pinch Of Prudence Seeking Alpha’s Quant Rating on ADMA Biologics Historical earnings data for ADMA Biologics Financial information for ADMA Biologics Fo...

3Q2023 Total Revenues of $67.3 Million, a 64% Y-o-Y Increase First-Time Positive GAAP Net Income of $2.6 Million First-Time Positive Operating Cash Flow of $12.0 Million, Growing Total Cash Balance to $74.2 Million 3Q2023 Adjusted EBITDA ( 1) Grew to $12.7 Mi...

Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...

ADMA Biologics Inc (ADMA) is expected to report $-0.01 for Q3 2023

RAMSEY, N.J. and BOCA RATON, Fla., Nov. 01, 2023 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologi...

2023-10-19 17:11:44 ET Gainers: PacWest Bancorp ( PACW ) +7% . Biomea Fusion ( BMEA ) +5% . Bank OZK ( OZK ) +3% . ADMA Biologics ( ADMA ) +3% . Revance Therapeutics ( RVNC ) +3% . Losers: SolarEdge Technologies ( SEDG ...